COGNITION THERAPEUTICS INC
CGTX · XNASCIK 1455365fmd_12DQTWQ06533FN9YQ552BNQTYQManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2020 to Sep 30, 2026, 27 periods
Latest annual · FY2025
Millions- Operating income
- (48)
- Net income
- (23)
Latest quarter · Q3 FY2026
Millions- Operating income
- (7)
- Net income
- (4)
- Free cash flow
- (3)
Key stats
Open AnalysisCompound annual growth
- Net income, 5 yearsFY2020 to FY2025
- n/m
COGNITION THERAPEUTICS INC (CGTX) financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2025 | FY2024 | Change | Source |
|---|---|---|---|---|
| Operating income | -$47.8 million | -$54 million | 10-K 2026-03-26 · proof | |
| Net income | -$23.5 million | -$34 million | 10-K 2026-03-26 · proof | |
| Cash from operating activities | -$24.6 million | -$28.5 million | 10-K 2026-03-26 · proof | |
| Total assets | $48.4 million | $30.2 million | +60.1% | 10-K 2026-03-26 · proof |
| Total liabilities | $14.1 million | $11.5 million | +22.9% | 10-K 2026-03-26 · proof |
| Cash and cash equivalents | $36.8 million | $25 million | +47.2% | 10-K 2026-03-26 · proof |
- What was COGNITION THERAPEUTICS INC (CGTX)'s operating income in fiscal 2025?
- COGNITION THERAPEUTICS INC (CGTX) reported operating income of -$47.8 million for fiscal 2025 (the year ended Dec 31, 2025), against -$54 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was COGNITION THERAPEUTICS INC (CGTX)'s net income in fiscal 2025?
- COGNITION THERAPEUTICS INC (CGTX) reported net income of -$23.5 million for fiscal 2025 (the year ended Dec 31, 2025), against -$34 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What was COGNITION THERAPEUTICS INC (CGTX)'s cash from operating activities in fiscal 2025?
- COGNITION THERAPEUTICS INC (CGTX) reported cash from operating activities of -$24.6 million for fiscal 2025 (the year ended Dec 31, 2025), against -$28.5 million the year before. Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are COGNITION THERAPEUTICS INC (CGTX)'s total assets?
- As of Dec 31, 2025, COGNITION THERAPEUTICS INC (CGTX) reported total assets of $48.4 million, against $30.2 million a year earlier (+60.1%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are COGNITION THERAPEUTICS INC (CGTX)'s total liabilities?
- As of Dec 31, 2025, COGNITION THERAPEUTICS INC (CGTX) reported total liabilities of $14.1 million, against $11.5 million a year earlier (+22.9%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
- What are COGNITION THERAPEUTICS INC (CGTX)'s cash and cash equivalents?
- As of Dec 31, 2025, COGNITION THERAPEUTICS INC (CGTX) reported cash and cash equivalents of $36.8 million, against $25 million a year earlier (+47.2%). Source: the 10-K filed with the SEC on Mar 26, 2026. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=ticker:CGTX&period_type=annual&limit=5"Information only, not investment advice.